• Home
  • Events
  • Biostatistics Seminar Series: Bayesian Clinical Trial Design
Month Flat Week Day
Date: Friday, November 06, 2020 10:30 am - 12:00 pm

In the third and final session of the NC TraCS Biostatistics Fall 2020 Seminar series, we consider the problem of Bayesian sample size determination for a clinical trial in the presence of historical data that inform the treatment effect. Our broadly applicable, simulation-based methodology provides a framework for calibrating the informativeness of a prior while simultaneously identifying the minimum sample size required for a new trial such that the overall design has appropriate power to detect a non-null treatment effect and reasonable type I error control. We demonstrate our methodology using a real data set to design a follow-up clinical trial with time-to-event endpoint for an investigational treatment in high-risk melanoma.

Presenter
Joeseph Ibrahim, PhD
UNC Department of Biostatistics

Register

The NC TraCS Biostatistics Seminar Series provides more in-depth discussion of select biostatistical topics for clinical and translational researchers who have basic quantitative training in biostatistical methods. Join us this fall for seminars on data visualization & statistical graphics, power analysis & sample size planning, and Bayesian clinical trial design.

Get NC TraCS events and news delivered to your inbox! Subscribe to our weekly email blast

Need help advertising your event? Contact Michelle Maclay at michelle_maclay@med.unc.edu

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UM1TR004406

© 2008-2024 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact